Richter et al. developed the [18F]FDG-conjugated bombesin analog QWAV-Sar-H-FA01010-Tle-NH2 ([18F]FDG-AOAc-BBN2, 54) for PET imaging of gastrin-releasing peptide (GRP) receptor-expressing prostate tumors by PET [69]. Here, GRP is linked to prostate neoplasm.